J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 66 (1985), 2523-2531; DOI 10.1099/0022-1317-66-12-2523
© 1985 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buckley, A.
Right arrow Articles by Gould, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buckley, A.
Right arrow Articles by Gould, E. A.
Agricola
Right arrow Articles by Buckley, A.
Right arrow Articles by Gould, E. A.

Neutralization of Yellow Fever Virus Studied Using Monoclonal and Polyclonal Antibodies

A. Buckley and E. A. Gould

London School of Hygiene and Tropical Medicine, Arbovirus Research Unit, Winches Farm Field Station, 395 Hatfield Road, St Albans, Hertfordshire AL4 0XQ, U.K.

Monoclonal and polyclonal antibodies with known specificity for either the 54K envelope glycoprotein or the 48K non-structural glycoprotein of yellow fever (YF) virus-infected cells were studied in plaque reduction neutralization tests. Viruses employed in the tests comprised wild-type and vaccine strains of YF and a selection of other flaviviruses. Of 17 monoclonal antibodies examined, six of the 54K-specific antibodies neutralized at least one YF preparation. Both vaccine and wild-type YF viruses varied in their susceptibility to neutralization and there were also differences between individual 17D vaccine strains. The monoclonal antibodies produced a range of titres with the different viruses, the most potent, 864, leaving no non-neutralizable fraction. Addition of anti-globulin, complement or other antibodies did not affect the results. YF-neutralizing antibodies which bound to other flaviviruses did not necessarily neutralize them; hence, neutralization could be defined as either homotypic, heterotypic or both homotypic and heterotypic. A polyclonal antiserum and a broadly reacting monoclonal antibody produced almost identical neutralization results in tests with wild-type YF viruses. In contrast, the polyclonal antiserum produced higher titres with vaccine strains of YF. In mouse passive protection experiments on the other hand, the monoclonal antibody did not differentiate between these viruses.

Keywords: YF virus, monoclonal antibodies, neutralization

Received 24 July 1985; accepted 12 September 1985.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. A. Maillard, M. Jordan, D. W. C. Beasley, A. D. T. Barrett, and J. C. Lee
Long Range Communication in the Envelope Protein Domain III and Its Effect on the Resistance of West Nile Virus to Antibody-mediated Neutralization
J. Biol. Chem., January 4, 2008; 283(1): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Stiasny, S. Kiermayr, H. Holzmann, and F. X. Heinz
Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites
J. Virol., October 1, 2006; 80(19): 9557 - 9568.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Buckley, A. Dawson, S. R. Moss, S. A. Hinsley, P. E. Bellamy, and E. A. Gould
Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK
J. Gen. Virol., October 1, 2003; 84(10): 2807 - 2817.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. S. Gritsun, T. V. Frolova, A. I. Zhankov, M. Armesto, S. L. Turner, M. P. Frolova, V. V. Pogodina, V. A. Lashkevich, and E. A. Gould
Characterization of a Siberian Virus Isolated from a Patient with Progressive Chronic Tick-Borne Encephalitis
J. Virol., December 6, 2002; 77(1): 25 - 36.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1985 by the Society for General Microbiology.